Vaccinex Inc (VCNX) - Sotuvning yalpi marjinal rentabelligi

Vaccinex, Inc (VCNX) kompaniyasining rasmiy ramzlari

Vaccinex, Inc. (VCNX) kompaniyasining neyrodegeneratsiya va o'smalarga qarshi kurashish uchun SEMA4D blokadasiga e'tibor qaratishi narxlar dinamikasini boshqarmoqda. Choraklik yalpi foyda ko'rsatkichi joriy tendentsiyani aks ettiradi, bunda 0.00 darajasi joriy qiymatni ifodalaydi. Pepinemab patent doirasi klinikalarni kompaniyaning protokollariga bog'laydi, biroq yagona antitanachi platformasiga to'liq bog'liqlik dori vositasi tijorat tasdig'ini olguniga qadar binar xavfni yuzaga keltiradi.

vaccinex.com (VCNX) - Yalpi marja 04.07.2022dan 28.12.2024gacha

Vaccinex, Inc. (VCNX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:Vaccinex, Inc.
Vaccinex Inc brend mahsuloti

Yalpi marja biznes modelining barqarorligini baholash uchun aktivlarning stress-testlari davomida muhim filtr vazifasini o'taydi. Ushbu metrika bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini o'lchab, xarajatlarni boshqarish samaradorligi va narx belgilash imkoniyatlarini aks ettiradi. Yalpi foyda marjasini tahlil qilish orqali investor Vaccinex, Inc. (VCNX) immunoterapiya platformasining innovatsion salohiyati maqsadli antitelalarni ishlab chiqishda qanchalik real moliyaviy samaradorlikka aylanayotganini baholashi mumkin.

Asosiy raqobatchilar

Yalpi foyda marjasi ImmunityBio Corp (IBRX)|Yalpi foyda bo'yicha rentabellik IMCR|JANX - Sotuvning yalpi marjinal rentabelligi|Yalpi foyda bo'yicha rentabellik RCUS (Arcus Bio)|Yalpi foyda koeffitsiyenti ZYME|Yalpi marja TNGX (Tango Therapeutics, Inc.)|Yalpi foyda normasi IOVA|immatics.com - Yalpi marja|Yalpi foyda marjasi Xencor Inc.|Compass Therapeutics (CMPX) - Yalpi rentabellik|Replimune Group, Inc. - Yalpi foyda normasi|LYEL (lyell.com) - Yalpi marja|Yalpi marja Innate Pharma SA|Yalpi rentabellik pyxisoncology.com (PYXS)|CGEN: Yalpi foyda bo'yicha marjinallik|IO Biotech Inc - Yalpi foyda bo'yicha rentabellik|sutrobio.com (STRO) - Yalpi foyda marjasi|INKT - Yalpi rentabellik|werewolftx.com (HOWL) - Yalpi foyda bo'yicha rentabellik|Immix (IMMX) - Yalpi rentabellik|ALXO (ALX Oncology Holdings) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik CUE|PDS Biotechnology Corporation (PDSB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Yalpi marja MAIA Biotechnology Inc (MAIA)|Yalpi rentabellik Liminatus Pharma LIMN|Yalpi foyda normasi LVTX|NXTC: Yalpi foyda bo'yicha rentabellik|leaptx.com - Yalpi foyda koeffitsiyenti|INTS: Yalpi marja|Sensei Biotherapeutics Inc - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik TOVX|Sotuvning yalpi rentabelligi GRTS (Gritstone bio, Inc.)|Yalpi foyda bo'yicha rentabellik KA (kinetabio.com)|NEXI - Yalpi foyda marjasi|Turnstone Biologics - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi HARP